NEW YORK (GenomeWeb News) — Orchid Cellmark yesterday closed its acquisition of DNA testing services provider Reliagene Technologies and today reported that its third-quarter revenue had inched back one percent, R&D spending fell 16 percent, and its net loss fell 46 percent.
 

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

A new analysis examines the gender gap among paper authors in the sciences and says it may take decades or more to close.

Researchers have uncovered signals of selection that may enable the Bajau people to free five hundreds of feet deep, Reuters reports.

In Science this week: paternally inherited cis-regulatory structural variants in autism, and more.

A new report outlines issues facing the implementation of personalized medicine in the UK, the Independent reports.